Press release
Androgens (Including DHEA) and FSH Are Crucial to Female Fertility, Suggests New Publication
August 23, 2011 (New York, NY) – Androgens (male hormones), contrary to popular belief, play a crucial role in women’s fertility. Some androgens and follicle-stimulating hormone (FSH) may work together to encourage development of eggs in the ovary in the early stages of oocyte (egg) maturation, investigators from a New York fertility center suggested in a recent article.In a paper just published in the journal Reproductive Biology and Endocrinology1, researchers from the Center for Human Reproduction (CHR) reached these conclusions combining results from human and recent mouse research. Some androgens, such as testosterone and dehydroepiandrosterone (DHEA), may make essential contributions to the normal maturation of follicles that contain eggs in the ovary.
Androgen’s role in female fertility has been controversial at best. Some researchers have even insisted that androgens are the principal enemy of follicle maturation, especially given observations in patients with polycystic ovarian syndrome (PCOS), who often present with excess androgens and tend to struggle with infertility.
“Recent research data suggests that androgens and FSH, likely at specific, balanced concentrations, work together in promoting follicle development,” explains Norbert Gleicher, MD, lead author of the paper, and Medical Director of CHR. “Investigations of such intricacies of ovarian function cannot be done in humans, at least initially, and requires integration of animal data, which is exactly what we did.”
The synergism between androgens and FSH appears most pronounced in the pre-antral and early antral stages of follicle maturation, at least 2-3 months before an egg is ready for ovulation. “This may open new avenues for treatment, especially for women with ‘older’ ovaries,” says David H Barad, MD, another author of the study. “Instead of focusing only on the last two weeks of oocyte maturation, as we currently do with infertility treatments, we may be able to offer treatments that benefit follicle development from much earlier maturation stages.”
Dr. Gleicher notes in the publication that doctors at CHR have preliminary evidence that longer-term exposure to DHEA in combination with FSH may positively affect oocyte development, though more definite conclusions require further studies.
1Gleicher N, Weghofer A, Barad DH. The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment? Reprod Biol Endocrinol 2011;9(1):116.
Original article: http://www.centerforhumanreprod.com/news_androgens_egg_development.html
About Center for Human Reproduction
Center for Human Reproduction (http://www.centerforhumanreprod.com) is a leading IVF center in New York City with world-wide clientele, well recognized for its major clinical research program, which over the years contributed a number of essential breakthroughs to the IVF process. Dr. Gleicher and Dr. Barad are available for further comments.
Communications Manager
212-994-4400
CHR - New York
21 E. 69th Street
New York, NY 10021
webadmin@thechr.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Androgens (Including DHEA) and FSH Are Crucial to Female Fertility, Suggests New Publication here
News-ID: 188926 • Views: …
More Releases from Center for Human Reproduction

IVF Success Rates Not Improved by Preimplantation Genetic Screening, According t …
There is no evidence that recent technical improvements in preimplantation genetic screening (PGS) improve IVF pregnancy chances, according to a paper just published online in the Journal of Assisted Reproduction and Genetics1. The review, by two fertility specialists from New York’s Center for Human Reproduction (CHR), raises important questions, as this “new” PGS is actively marketed to patients as “proven” and “established” to increase IVF success rates.
In the late ‘90s,…

Research from CHR Offers Hope for Women with Treatment-Resistant Thin Endometriu …
November 15, 2012 (New York, NY) – Direct perfusion of the endometrial cavity with granulocyte colony-stimulating factor (G-CSF) improves the thickness of the endometrial lining in IVF patients with too thin endometrium even after treatments, according to a new study just published online in the medical journal Human Reproduction(1).
In the study, 21 women undergoing in vitro fertilization (IVF) cycles at the Center for Human Reproduction (CHR) in New York City…

FMR1 Gene May Control Women’s Fertility Life Cycle, According to Research
October 23, 2012 (New York, NY) – A new study presented at the Annual Meeting of the American Society for Reproductive Medicine (ASRM) in San Diego, CA, offers further evidence that the fragile X mental retardation 1 gene (FMR1 gene) may play an important role in controlling women’s fertility life cycles.
The study, conducted by researchers from the Center for Human Reproduction (CHR), a leading fertility center in New York…

BRCA1/2 Mutation and FMR1 Gene Study Has Potential Implications for Cancer Scree …
BRCA1/2 gene mutations, widely associated with breast and ovarian cancer risks in women, are, in principle, lethal to human embryos, according to new research conducted by three teams of researchers from the Center for Human Reproduction (CHR) in New York City, the Medical University Vienna in Vienna, Austria, and the Medical University Graz, Graz, Austria. BRCA1/2-positive embryos will only survive when also carrying a specific FMR1 gene genotype.
In a paper…
More Releases for FSH
Follicle Stimulating Hormone (FSH) ELISA Test Kit Market Key Players, Share and …
"The global market for Follicle Stimulating Hormone (FSH) ELISA test kits is valued at approximately $260 million in 2024. This sector is projected to experience significant growth, with an estimated market value reaching around $430 million by 2034. This represents a Compound Annual Growth Rate (CAGR) of approximately 5.2% from 2025 to 2034."
Exactitude Consultancy., Ltd. released a research report titled "Follicle Stimulating Hormone (FSH) ELISA Test Kit Market". This report…
Follicle-Stimulating Hormone (FSH) Market 2022 - 2030: Rising Demand for Inferti …
Follicle-stimulating hormone (FSH) is a hormone that plays a crucial role in regulating the menstrual cycle and reproductive system in women. The increasing incidence of infertility, changing lifestyle patterns, and the growing number of women opting for assisted reproductive techniques are driving the growth of the FSH market. In addition, the rising awareness about infertility treatments, increasing disposable income, and the growing number of infertility clinics and hospitals are also…
Veterinary Follicle Stimulating Hormones (FSH) Market Booming Worldwide( Forecas …
The global Veterinary Follicle Stimulating Hormones (FSH) market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Veterinary Follicle Stimulating Hormones (FSH) market. For instance, the market dynamics section digs deep into the drivers, restraints,…
Global Veterinary Follicle Stimulating Hormones (FSH) Market Size,Share, Analysi …
Los Angeles, United States November 2022,- The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Veterinary Follicle Stimulating Hormones (FSH) market. It sheds light on how the global Veterinary Follicle Stimulating Hormones (FSH) market is expected to grow during the course of the forecast period. With SWOT analysis and Porter's Five Forces analysis, it gives a deep explanation of the…
Global Follicle Stimulating Hormone (FSH) Market Top Leading Players with Strate …
The global follicle stimulating hormone (FSH) market is anticipated to grow at a significant CAGR 5% during the forecast period (2022-2028). The gonadotropic hormone is secreted by the anterior pituitary gland. It supports in the development of pubertal maturation and the reproductive process. The major factor expected to drive the market is increasing adoption of assisted reproductive technology (ART) and the rising number of infertility patients seeking treatment. Moreover, hypothalamic…
Follicle-stimulating Hormone (FSH) Market : New Business Opportunities and Inves …
In 2017, the global Follicle-stimulating Hormone (FSH) market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Follicle-stimulating Hormone (FSH) market based on company, product type, application and key regions.
This report studies the global market size of Follicle-stimulating Hormone (FSH) in key regions like North…